720 related articles for article (PubMed ID: 16489061)
1. The role of interleukin 1 in growth and metastasis of human cancer xenografts.
Elaraj DM; Weinreich DM; Varghese S; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Alexander HR
Clin Cancer Res; 2006 Feb; 12(4):1088-96. PubMed ID: 16489061
[TBL] [Abstract][Full Text] [Related]
2. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.
Weinreich DM; Elaraj DM; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Spiess PJ; Alexander HR
Cancer Res; 2003 Sep; 63(18):5957-61. PubMed ID: 14522922
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
McKenzie RC; Oran A; Dinarello CA; Sauder DN
Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
[TBL] [Abstract][Full Text] [Related]
4. The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1 beta.
Watson JM; Lofquist AK; Rinehart CA; Olsen JC; Makarov SS; Kaufman DG; Haskill JS
J Immunol; 1995 Nov; 155(9):4467-75. PubMed ID: 7594609
[TBL] [Abstract][Full Text] [Related]
5. Interleukin (IL)-1beta regulation of IL-1beta and IL-1 receptor antagonist expression in cultured human endometrial stromal cells.
Huang HY; Wen Y; Kruessel JS; Raga F; Soong YK; Polan ML
J Clin Endocrinol Metab; 2001 Mar; 86(3):1387-93. PubMed ID: 11238536
[TBL] [Abstract][Full Text] [Related]
6. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system.
Chirivi RG; Garofalo A; Padura IM; Mantovani A; Giavazzi R
Cancer Res; 1993 Oct; 53(20):5051-4. PubMed ID: 8267795
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma.
Masood R; Cai J; Tulpule A; Zheng T; Hamilton A; Sharma S; Espina BM; Smith DL; Gill PS
Clin Cancer Res; 2001 Sep; 7(9):2693-702. PubMed ID: 11555581
[TBL] [Abstract][Full Text] [Related]
10. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
11. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
Harada K; Supriatno ; Yoshida H; Sato M
Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK
Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.
Gong Z; Ma J; Su H; Guo T; Cai H; Chen Q; Zhao X; Qi J; Du J
Int J Clin Oncol; 2018 Aug; 23(4):659-670. PubMed ID: 29344744
[TBL] [Abstract][Full Text] [Related]
14. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
Pantschenko AG; Pushkar I; Anderson KH; Wang Y; Miller LJ; Kurtzman SH; Barrows G; Kreutzer DL
Int J Oncol; 2003 Aug; 23(2):269-84. PubMed ID: 12851675
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro.
Vidal-Vanaclocha F; Alvarez A; Asumendi A; Urcelay B; Tonino P; Dinarello CA
J Natl Cancer Inst; 1996 Feb; 88(3-4):198-205. PubMed ID: 8632494
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
17. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.
Balbay MD; Pettaway CA; Kuniyasu H; Inoue K; Ramirez E; Li E; Fidler IJ; Dinney CP
Clin Cancer Res; 1999 Apr; 5(4):783-9. PubMed ID: 10213213
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1alpha, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer.
Tang RF; Wang SX; Zhang FR; Peng L; Wang SX; Xiao Y; Zhang M
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):460-3. PubMed ID: 16109537
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
La E; Muga SJ; Locniskar MF; Fischer SM
Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
[TBL] [Abstract][Full Text] [Related]
20. Effects of interleukin-1 receptor antagonist and chemotherapy on host-tumor interactions in established melanoma.
Triozzi PL; Aldrich W
Anticancer Res; 2010 Feb; 30(2):345-54. PubMed ID: 20332438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
